Mycoplasma Testing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product & Service (Kits & Reagents, Instruments and Services); Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and Other Applications); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users), and Geography
Report Code: TIPRE00003516 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Testing for mycoplasma contamination is an essential practice in the process of cell culturing. Mycoplasma are small, simple bacteria, they represent one of the most prevalent and serious sources of cell line contamination. Since, these organisms lack a cell wall, they have a rapid mode of infecting the entire cell culture, causing loss on a large scale. Hence, in order to obtain better results, various companies have been providing solutions for testing mycoplasma contamination.
MARKET DYNAMICS
The mycoplasma testing market is anticipated to grow in the forecast, owing to increasing support and growth opportunity provided by biotechnology as well as the pharmaceutical industry, along with strong R&D investments in life sciences. In addition, increasing pharmaceutical outsourcing is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Global Mycoplasma Testing Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of mycoplasma testing market with detailed market segmentation by product & services, application, end user, and geography. The global mycoplasma testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading mycoplasma testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global mycoplasma testing market is segmented on the basis of product & services, application and end user. Based on product & services, the market is segmented as kits & reagents, instruments and services. On the basis of application, the global mycoplasma testing market is segmented into, cell line testing, virus testing, end-of-production cell testing and other applications. Similarly, based on end user, the market is categorized as, pharmaceutical and biotechnology companies, contract research organizations, academic research institutes and other end users
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global mycoplasma testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mycoplasma testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting mycoplasma testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mycoplasma testing market in these regions.
Get more information on this report :
MARKET PLAYERS
The reports cover key developments in the mycoplasma testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from mycoplasma testing market are anticipated to lucrative growth opportunities in the future with the rising demand for mycoplasma testing market in the global market. Below mentioned is the list of few companies engaged in the mycoplasma testing market.
The report also includes the profiles of key mycoplasma testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Agilent Technologies, Inc.
- Charles River
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
- Lonza
- Merck KGaA
- Minerva Biolabs
- Sartorius AG
- SGS SA
- Thermo Fisher Scientific Inc.
The List of Companies
1. Agilent Technologies, Inc.
2. Charles River
3. Eurofins Scientific
4. F. Hoffmann-La Roche Ltd
5. Lonza
6. Merck KGaA
7. Minerva Biolabs
8. Sartorius AG
9. SGS SA
10. Thermo Fisher Scientific Inc.
1. Agilent Technologies, Inc.
2. Charles River
3. Eurofins Scientific
4. F. Hoffmann-La Roche Ltd
5. Lonza
6. Merck KGaA
7. Minerva Biolabs
8. Sartorius AG
9. SGS SA
10. Thermo Fisher Scientific Inc.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount